Amy Martin
Psychiatric/Mental Health · Jeffersonville, INNPI 1770130122
Payments from drug & device makers
Across 201 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$953
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$286
- Teva Pharmaceuticals USA, Inc.$209
- Johnson & Johnson$204
- Otsuka America Pharmaceutical, Inc.$201
- Alkermes, Inc.$188
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,076100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $953 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $286 |
| Teva Pharmaceuticals USA, Inc. | 15 | $209 |
| Johnson & Johnson | 12 | $204 |
| Otsuka America Pharmaceutical, Inc. | 10 | $201 |
| Alkermes, Inc. | 16 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $147 |
| Lundbeck LLC | 10 | $136 |
| Axsome Therapeutics, Inc. | 6 | $130 |
| Corium, LLC | 8 | $122 |
| Ironshore Pharmaceuticals Inc. | 4 | $69 |
| Indivior Inc. | 3 | $67 |
| Neurocrine Biosciences, Inc. | 3 | $58 |
| Tris Pharma Inc | 3 | $54 |
| Neos Therapeutics, LP | 2 | $48 |
| Noven Therapeutics, LLC | 3 | $48 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Bausch Health US, LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$226
How this compares
$3,076 in reported general payments places this provider in the 80th percentile of 729 psychiatric/mental health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 16 | $777 |
| Vilazodone Hcl | 11 | $518 |
| Duloxetine Hcl | 36 | $503 |
| Hydroxyzine Hcl | 51 | $460 |
| Buspirone Hcl | 47 | $421 |
| Olanzapine | 22 | $271 |
| Bupropion Hcl | 20 | $260 |
| Bupropion XlBupropion Hcl | 13 | $232 |
| Citalopram HbrCitalopram Hydrobromide | 17 | $152 |
| Sertraline Hcl | 40 | $146 |
| Trazodone Hcl | 42 | $136 |
| Mirtazapine | 26 | $128 |
| Quetiapine Fumarate | 13 | $124 |
| Bupropion Hcl SrBupropion Hcl | 12 | $59 |
| Escitalopram Oxalate | 17 | $43 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Jeffersonville
- Paul DuncanJeffersonville$46K
- Anthony AemmerJeffersonville$9K
- Matthew CulbrethJeffersonville$7K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.